First Citizens Bank & Trust’s Haemonetics HAE Stock Holding History

First Citizens Bank & Trust’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,694	Closed	-$299K	–	419
2021 Q1	$299K	Buy	2,694 +767	+40%	+$94.9K	0.01%	298
2020 Q4	$229K	Buy	+1,927	New	+$207K	0.01%	334
2019 Q4	–	Sell	-1,711	Closed	-$216K	–	378
2019 Q3	$216K	Sell	1,711 -1,459	-46%	-$185K	0.03%	326
2019 Q2	$381K	Buy	3,170 +10	+0.3%	+$984	0.04%	325
2019 Q1	$276K	Buy	3,160 +865	+38%	+$78.7K	0.03%	366
2018 Q4	$230K	Buy	+2,295	New	+$241K	0.03%	360

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

First Citizens Bank & Trust's HAE Position: Q2 2021 in Review

First Citizens Bank & Trust sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 2,694 shares — an estimated $299K sold.

First Citizens Bank & Trust first reported a position in HAE in Q4 2018 and held it in 6 quarters. The position peaked at $381K in Q2 2019. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

First Citizens Bank & Trust reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
First Citizens Bank & Trust sold 2,694 Haemonetics shares in Q2 2021, an estimated $299K.
First Citizens Bank & Trust first reported a position in Haemonetics in Q4 2018 and held it in 6 quarters.
First Citizens Bank & Trust's Haemonetics position peaked at $381K in Q2 2019.
258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on First Citizens Bank & Trust's 13F filing for Q2 2021, filed 14 Jul 2021.